Skip to main content

Advertisement

Log in

Re-Transurethral Resection Treatment for Non-invasive Bladder Tumor

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The objective of this study was to compare surgical treatments for non-invasive bladder tumor. Hundred and forty patients with non-invasive bladder tumor were studied. Seventy-three patients were treated by transurethral resection of bladder tumor (TURBT) and Repeated-Transurethral Resection of Bladder Tumor (R-TURBT), while 67 by partial cystectomy. Operation time, blood loss, postoperative complications, and postoperative recurrence rate were better in the TURBT+R-TURBT group compared with the partial cystectomy group. Further, TURBT+R-TURBT offers advantages, such as simple surgical manipulation, less trauma, faster recovery, repeatedly performable procedure, and safety. In conclusion, this is an optimal therapy for treatment of non-invasive bladder tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

TURBT:

Transurethral Resection of Bladder Tumor

R-TURBT:

Repeated-Transurethral Resection of Bladder Tumor

THP:

Therarubicin Pirarubicin

References

  1. Xu, B., & Hua, L. (2007). Epidemiology of bladder cancer. International Urology and Nephrology, 27, 469–476.

    Google Scholar 

  2. Paul, R., Kübler, H., van Randenborgh, H., & Hartung, R. (2002). Prognostic significance of the TNM-Staging-System of 1987 and 1997 as compared to the Robson-classification for renal cell cancer. Actuellement Urology, 33, 531–539.

    Google Scholar 

  3. Pellucchi, F., Freschi, M., Ibrahim, B., Rocchini, L., Maccagnano, C., Briganti, A., et al. (2011). Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. Journal of Urology, 186, 2194–2199.

    Article  PubMed  Google Scholar 

  4. Hollenbeck, B. K., Miller, D. C., Taub, D., Dunn, R. L., Khuri, S. F., Henderson, W. G., et al. (2006). Risk factors for adverse outcomes after transurethral resection of bladder tumors. Cancer, 106, 1527–1535.

    Article  PubMed  Google Scholar 

  5. Barnes, R. V. (1996). Treatment of superficial bladder tumors with transurethral resection clinical analzsis of 505 cases. Journal of Urology, 97, 864.

    Google Scholar 

  6. Zhou, R. (1996). Bladder Surgery. Beijing: People’s Medical Publishing House. in Chinese.

    Google Scholar 

  7. Manoharan, M., & Soloway, M. S. (2005). Optimal management of the T1G3 bladder cancer. Urologic Clinics of North America, 32, 133–145.

    Article  PubMed  Google Scholar 

  8. Masood, S., Sriprasad, S., Palmer, J. H., & Mufti, G. R. (2004). T1G3 bladder cancer: Indications for early cystectomy. International Urology and Nephrology, 36, 41–44.

    Article  CAS  PubMed  Google Scholar 

  9. Wu, T., Zhang, J., & Wang, F. (2006). Prevention and treatment of recurrence of superficial bladder cancer by postoperative intravital instillation of pirarubicin (report of 109 cases). Journal of Southeast University, 25, 113–115. in Chinese.

    Google Scholar 

  10. Wu, X., Lu, S., & Cai, L. (2005). Application of multidrug resistance of bladder tumor cell in the treatment of invasive bladder tumor. Journal of Southeast University, 24, 374–376. in Chinese.

    CAS  Google Scholar 

  11. Wu, J. (2004). Wu Jie-Ping’s Urology. Jinan: Shandong Science and Technology Press. in Chinese.

    Google Scholar 

  12. Kriegmair, M., Zaak, D., Rothenberger, K. H., Rassweiler, J., Jocham, D., Eisenberger, F., et al. (2002). Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. Journal of Urology, 168, 475–478.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Conghui Han, Zhenduo SHI, and Xujun Xuan contributed equally to this work and should be considered as co-first authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dong Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, Ch., Shi, Z., Xuan, X. et al. Re-Transurethral Resection Treatment for Non-invasive Bladder Tumor. Cell Biochem Biophys 69, 589–592 (2014). https://doi.org/10.1007/s12013-014-9837-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-9837-3

Keywords

Navigation